Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Equity (2021 - 2025)

iSpecimen has reported Return on Equity over the past 5 years, most recently at 2.91% for Q4 2025.

  • Quarterly results put Return on Equity at 2.91% for Q4 2025, up 29.0% from a year ago — trailing twelve months through Dec 2025 was 2.91% (up 29.0% YoY), and the annual figure for FY2025 was 2.81%, down 84.0%.
  • Return on Equity for Q4 2025 was 2.91% at iSpecimen, up from 6.65% in the prior quarter.
  • Over the last five years, Return on Equity for ISPC hit a ceiling of 0.58% in Q2 2021 and a floor of 9.75% in Q2 2025.
  • Median Return on Equity over the past 5 years was 0.71% (2023), compared with a mean of 1.8%.
  • Peak annual rise in Return on Equity hit 29bps in 2025, while the deepest fall reached -818bps in 2025.
  • iSpecimen's Return on Equity stood at 0.23% in 2021, then plummeted by -113bps to 0.48% in 2022, then tumbled by -101bps to 0.97% in 2023, then plummeted by -232bps to 3.2% in 2024, then rose by 9bps to 2.91% in 2025.
  • The last three reported values for Return on Equity were 2.91% (Q4 2025), 6.65% (Q3 2025), and 9.75% (Q2 2025) per Business Quant data.